Project ECHO: Approaches to Long-Term Weight Loss and Obesity Care

Each ECHO will have a live, interactive seminar and on-demand component; please note that participation in the live event is limited to 25 persons per event and that those who participate in the live ECHO may receive credit from the live event but are not eligible to also receive credit for the on-demand seminar. 

Endocrine Society is pleased to participate in Project ECHO: Approaches to Long-Term Weight Loss and Obesity Care.

Open to all clinicians, this program seeks to educate primary care providers, care teams, and non-obesity specialists in best practices in obesity care and management. With many therapeutic and pharmacological options available, clinicians need additional resources to stay up-to-date in obesity management. This program, featuring live, interactive seminars and on-demand webinars, will focus on evidence-based methods for addressing obesity and managing its comorbidities in a compassionate manner, with a goal of ending stigma and improving health-related quality-of-life for patients. The aim is to address the obesity epidemic and associated diseases by educating clinicians around the world in best-practices and research directly from obesity-management specialists. There will be a total of 12 ECHOs throughout the next year, each focusing on a different aspect of obesity and associated comorbidities.

Project ECHO started at the University of New Mexico in 2003. ECHO stands for Extension of Community Healthcare Outcomes, and it is built on the idea that while not everyone can be a specialist, all patients deserve access to specialty care. Using a hub and spoke model, and virtual platforms like Zoom, specialists are able to connect with non-specialist providers in real time to provide education and feedback on cases. Our ECHOs, which will focus on the management of obesity, will be held on a monthly basis as live and on-demand webinars. This educational activity is supported by an independent medical educational grant from Novo Nordisk Inc. 

You will not be able to register for each individual ECHO until you have completed registration for the entire program using the register tab. As registration opens for each individual ECHO, you can click each hyperlink below to learn more about the upcoming ECHO. You can review speakers and topics in the program tab. Once registered for the ECHO, you will be able to submit a case or question on that topic. 

ECHO 1: Perception is More Important than Reality – Aligning Beliefs of Patients and Providers to Promote Actions in Effective Weight Management 

ECHO 2: Initial Assessment of a Person Presenting for Weight Management 

ECHO 3: Weightier Matters - Intensive Lifestyle Interventions

ECHO 4: Bariatric surgery and outcomes

ECHO 5: Comparison of pharmacologic therapies, including combining weight loss meds and coverage

ECHO 6: Treating obesity in the context of T2DM, with a focus on weight loss in patients on insulin, weight loss drugs, and weight negative anti-diabetic

ECHO 7: Intermittent fasting, time restricted feeding, and the biologic clock

ECHO 8: Adolescent obesity

ECHO 9: Matters of energy expenditure for long-term weight maintenance

ECHO 10: Obesity and the heart 

ECHO 11: Obesity and women’s reproduction: optimizing fertility, pre-conception weight, and maternal-fetal outcomes 

ECHO 12: Psychological health and obesity

Target Audience

This program will be of substantial interest to endocrinologists and fellows caring for individuals with, or at risk for developing, obesity and associated diseases. Additionally, this program may be of interest to primary care professionals and advance practice professionals who treat patients with obesity.

Learning Objectives

Upon completing this series, learners will be able to:

•    Identify new and emerging trends in obesity medicine and management;
•    Identify and review available and emerging therapeutic approaches to obesity management;
•    Review different approaches to weight loss/maintenance.

Additional Information

Target Audience: 
Physician-in-practice
Fellow
Resident
Clinical researcher
Scientific researcher
Educator/Teacher
Pharmacist
Nurse/Nurse practitioner
Physician assistant
Allied health professional
Other
Competency Area: 
Patient Care and Procedural Skills
Medical Knowledge
Topic Area: 
Obesity
Level of Outcomes: 
Level 1 (Participation)
Level 2 (Satisfaction)
Level 3A (Learning: Declarative Knowledge (Knows))
Activity summary
Course opens: 
07/06/2020
Course expires: 
12/31/2023

Each ECHO will have a live and on-demand component; please note that participation in the live event is limited to 25 persons per event and that those who participate in the live ECHO may receive credit from the live event but are not eligible to receive credit for the on-demand webinar. 

Topic

Speaker(s)

Planned Date of ECHO
1. Myths, common misconceptions, and fads in obesity and obesity treatment

Donna H. Ryan, MD
(Pennington Biomedical Research Center)         

Tuesday, July 28, 2020
4pm PT, 5pm MT, 6pm CT, 7pm ET                                                     
2. Initial assessment/evaluation of a person presenting for weight management

Jonathan Purnell, MD
(Oregon Health and Science University)

Tuesday, August 25, 2020
4pm PT, 5pm MT, 6pm CT, 7pm ET
3. Lifestyle interventions and total diet meal replacement

Amy E. Rothberg, MD, PhD
(University of Michigan)

Tuesday, September 22, 2020
4pm PT, 5pm MT, 6pm CT, 7pm ET
4. Bariatric surgery and outcomes

Jamy Ard, MD
(Wake Forest School of Medicine)

Tuesday, October 20, 2020
4pm PT, 5pm MT, 6pm CT, 7pm ET
5. Comparison of pharmacologic therapies

Donna H. Ryan, MD
(Pennington Biomedical Research Center)

Guest Speaker TBA

Tuesday, November 17, 2020
4pm PT, 5pm MT, 6pm CT, 7pm ET
6. Treating obesity in the context of T2DM

Jonathan Purnell, MD
(Oregon Health and Science University)

Guest Speaker TBA

Tuesday, December 15, 2020
4pm PT, 5pm MT, 6pm CT, 7pm ET
7. Intermittent fasting, time restricted feeding, and the biologic clock

Amy E. Rothberg, MD, PhD
(University of Michigan)

Guest Speaker TBA

Tuesday, January 26, 2021
4pm PT, 5pm MT, 6pm CT, 7pm ET
8. Adolescent obesity

Jamy Ard, MD
(Wake Forest School of Medicine)

Guest Speaker TBA

Tuesday, February 23, 2021
4pm PT, 5pm MT, 6pm CT, 7pm ET
9. Matters of energy expenditure for long-term weight maintenance

Donna H. Ryan, MD
(Pennington Biomedical Research Center)

Guest Speaker TBA

Tuesday, March 16, 2021
4pm PT, 5pm MT, 6pm CT, 7pm ET
10. Obesity and the heart

Jonathan Purnell, MD
(Oregon Health and Science University)

Guest Speaker TBA

Tuesday, April 27, 2021
4pm PT, 5pm MT, 6pm CT, 7pm ET
11. Obesity and women’s reproduction: optimizing fertility, pre-conception weight, and maternal-fetal outcomes

Amy E. Rothberg, MD, PhD
(University of Michigan)

Guest Speaker TBA

Tuesday, May 25, 2021
4pm PT, 5pm MT, 6pm CT, 7pm ET
12. Psychological health and obesity

Jamy Ard, MD
(Wake Forest School of Medicine)

Guest Speaker TBA

Tuesday, June 22, 2021
4pm PT, 5pm MT, 6pm CT, 7pm ET

Faculty 

The core faculty for Project ECHO: Approaches to Long-Term Weight Loss and Obesity Care are:

Amy E. Rothberg, MD, PhD (Program Chair)
University of Michigan 

Jamy Ard, MD
Wake Forest School of Medicine 

Donna H. Ryan, MD
Pennington Biomedical Research Center

Jonathan Purnell, MD
Oregon Health and Science University

Peer Reviewer

Beret A. Casey, MD
Essentia Health

STATEMENT OF INDEPENDENCE

As a provider of CME accredited by the Accreditation Council for Continuing Medical Education, the Endocrine Society has a policy of ensuring that the content and quality of this educational activity are balanced, independent, objective, and scientifically rigorous. The scientific content of this activity was developed under the supervision of the Endocrine Society’s guideline task force.

DISCLOSURE POLICY

The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to the Endocrine Society and to learners any relevant financial relationship(s) of the individual or spouse/partner that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the content. Financial relationships are defined by remuneration in any amount from the commercial interest(s) in the form of grants; research support; consulting fees; salary; ownership interest (e.g., stocks, stock options, or ownership interest excluding diversified mutual funds); honoraria or other payments for participation in speakers' bureaus, advisory boards, or boards of directors; or other financial benefits. The intent of this disclosure is not to prevent planners with relevant financial relationships from planning or delivery of content, but rather to provide learners with information that allows them to make their own judgments of whether these financial relationships may have influenced the educational activity with regard to exposition or conclusion. The Endocrine Society has reviewed all disclosures and resolved or managed all identified conflicts of interest, as applicable.

The following faculty reported relevant financial relationships: Amy E. Rothberg, MD, PhD - Self: Rhythm, Consultant/Advisory; Spouse: Merck, Data Safety Monitoring Board. Jonathan Purnell, MD - Self: Novo Nordisk, Advisor Board - Global Obesity Program. Jamy Ard, MD - Self: Novo Nordisk, UnitedHealth Group, Boehringer-Ingelheim, Nestle Healthcare Nutrition, Consultant; Epitomee Medical, Research Grant.

The following faculty reported no relevant financial relationships: Donna H. Ryan, MD

Disclosure information for guest speakers is included in their individual recorded presentations.

The following peer reviewer reported no relevant financial relationships: Beret A. Casey, MD

Endocrine Society staff associated with the development of content for this activity reported no relevant financial relationships.

DISCLAIMERS

USE OF PROFESSIONAL JUDGMENT:
The educational content in this activity relates to basic principles of diagnosis and therapy and does not substitute for individual patient assessment based on the health care provider’s examination of the patient and consideration of laboratory data and other factors unique to the patient. Standards in medicine change as new data become available.

DRUGS AND DOSAGES:

When prescribing medications, the physician is advised to check the product information sheet accompanying each drug to verify conditions of use and to identify any changes in drug dosage schedule or contraindications.

POLICY ON UNLABELED/OFF-LABEL USE:

The Endocrine Society has determined that disclosure of unlabeled/off-label or investigational use of commercial product(s) is informative for audiences and therefore requires this information to be disclosed to the learners at the beginning of the presentation. Uses of specific therapeutic agents, devices, and other products discussed in this educational activity may not be the same as those indicated in product labeling approved by the Food and Drug Administration (FDA). The Endocrine Society requires that any discussions of such “off-label” use be based on scientific research that conforms to generally accepted standards of experimental design, data collection, and data analysis. Before recommending or prescribing any therapeutic agent or device, learners should review the complete prescribing information, including indications, contraindications, warnings, precautions, and adverse events.

PRIVACY AND CONFIDENTIALITY STATEMENT:

The Endocrine Society will record learner’s personal information as provided on CME evaluations to allow for issuance and tracking of CME certificates. The Endocrine Society may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its CME program. No individual performance data or any other personal information collected from evaluations will be shared with third parties.

ACKNOWLEDGMENT OF COMMERCIAL SUPPORT:

This educational activity is supported by an independent medical educational grant from Novo Nordisk Inc. 

Accreditation Statement

The Endocrine Society is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The Endocrine Society has achieved Accreditation with Commendation.

The Endocrine Society designates each live and enduring ECHO for 1.0 AMA PRA Category 1 Credit. Please note that you must claim credit at the individual ECHO level. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Each ECHO will have a live and on-demand component; please note that participation in the live event is limited to 25 persons per event and that those who participate in the live ECHO may receive credit from the live event but are not eligible to receive credit for the on-demand webinar. 

Please login using your Endocrine Society credentials. If you do not have an account with us, you will be prompted to create one.

To gain access to each live ECHO and the recordings for previous ECHOs, you must complete the program questionnaire by clicking 'Start.' Additionally, you will be asked to complete a short pre-survey for each ECHO you are interested in after registering on that activity's page.

Those registered for the live component will have access to a case submission portal after completing the pre-survey for each ECHO. This can be used to submit cases and questions specific to each topic.

Each live ECHO is open to 25 participants, and will take place in the evening on the 4th Tuesday of every month from July 2020 – June 2021. 

If you have any questions, please contact mgraham@endocrine.org